The role of DNA methylation in the pathophysiology and treatment of bipolar disorder
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Bipolar disorder (BD) is a multifactorial illness thought to result from an interaction between genetic susceptibility and environmental stimuli. Epigenetic mechanisms, including DNA methylation, can modulate gene expression in response to the environment, and therefore might account for part of the heritability reported for BD. This paper aims to review evidence of the potential role of DNA methylation in the pathophysiology and treatment of BD. In summary, several studies suggest that alterations in DNA methylation may play an important role in the dysregulation of gene expression in BD, and some actually suggest their potential use as biomarkers to improve diagnosis, prognosis, and assessment of response to treatment. This is also supported by reports of alterations in the levels of DNA methyltransferases in patients and in the mechanism of action of classical mood stabilizers. In this sense, targeting specific alterations in DNA methylation represents exciting new treatment possibilities for BD, and the ‘plastic’ characteristic of DNA methylation accounts for a promising possibility of restoring environment-induced modifications in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 1×
“…M anuscript A uthor M anuscript As a limitation, it is important to note that BDNF expression is highly dependent on the promoter being modulated (Pruunsild et al., 2007), as well as on genetic polymorphisms that can interfere with its processing and function (Egan et al., 2003; Hong et al., 2011).”
BackgroundGenetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431 · cited 1×
“…relatives of patients with mood disorders have a higher risk to develop psychiatric disorders than the general population (Potash and DePaulo, 2000; Sullivan et al., 2000), and that monozygotic twins have higher concordance rates than dizygotic twins for these phenotypes (Rice et al., 2002;…”
BackgroundGenomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501 · cited 1×
“…polymerase II recruitment and initiation of transcription, or by (b) actively recruiting repressor proteins such as methyl CpG binding protein 2 (MeCP2) and histone deacetylases (HDAC), which will ultimately lead to the formation of heterochromatin (Breiling and Lyko, 2015; Klose and Bird, 2006).”
BackgroundFunction and information content of DNA methylation
Schübeler, D. (2015) · Nature · doi:10.1038/nature14192 · Cited by 2,060 · cited 10×
“These domains can target and recruit other proteins, such as the CXXC finger protein 1 (CFP1) or the histone demethylase KDM2A and KDM2B, to help maintain the unmethylated state of a particular cytosine (Schubeler, 2015).”
BackgroundInfluentialPhiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · cited 2×
“In addition, valproate has been shown to be a potent inhibitor of HDACs (Phiel et al., 2001), which are believed to have a direct influence on DNA methylation (Dobosy and Selker, 2001).”
BackgroundConserved role of intragenic DNA methylation in regulating alternative promoters
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D’Souza, C., Fouse, S. D., Johnson, B. E., Hong, C., Nielsen, C., Zhao, Y., et al. (2010) · Nature · doi:10.1038/nature09165 · Cited by 1,743 · cited 2×
“Accordingly, gene body methylation has also been recently shown to increase gene expression by a series of potential mechanisms, including the blocking of initiation of intragenic promoters, interfering with the activity of repetitive DNAs within the transcription unit (Maunakea et al., 2010), or forming an ordered st…”
BackgroundGrande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W. W., Mercer, K. B., Mayberg, H. S., Bradley, B., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3275 · Cited by 1,447 · cited 1×
“FKBP5 is a negative modulator of the glucocorticoid receptor, and the methylation of specific intronic regions of its gene has been shown to modulate the receptor activity by interfering with the FKBP5 ultra-short feedback loop (Fries et al., 2015; Klengel et al., 2013).”
BackgroundSelf-citationGene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Yang, X., Han, H., De Carvalho, D. D., Lay, F. D., Jones, P. A., & Liang, G. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.028 · Cited by 1,199 · cited 2×
“, 2010), or forming an ordered structure within the nucleosome that might increase the rate of transcription either by elongation or splicing (Yang et al., 2014).”
BackgroundBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · cited 1×
“Of note, this inhibitory action appears to depend on FKBP51, a regulator of the glucocorticoid receptor (Wochnik et al., 2005) which has been implicated in antidepressant response (Binder et al., 2004; Gassen et al., 2015b; Gassen et al., 2014).”
BackgroundSelf-citationDynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives
Spruijt, C. G., Gnerlich, F., Smits, A. H., Pfaffeneder, T., Jansen, P. W. T. C., Bauer, C., Münzel, M., Wagner, M., Müller, M., Khan, F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.02.004 · Cited by 973 · cited 2×
“Of note, several other proteins have been shown to bind to 5hmC, 5fC and 5caC, including DNA glycosylases and DNA repair proteins, and each of them seems to recruit a distinct and dynamic set of proteins (Spruijt et al., 2013).”
BackgroundHolocaust Exposure Induced Intergenerational Effects on FKBP5 Methylation
Yehuda, R., Daskalakis, N. P., Bierer, L. M., Bader, H. N., Klengel, T., Holsboer, F., & Binder, E. B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.005 · Cited by 782 · cited 2×
“…measure the so-called ‘non genetic intergenerational transmission’ of DNA methylation patterns over generations (Weber-Stadlbauer et al., 2016; Yehuda et al., 2015), which will in fact demonstrate whether the risk shown by populations at familial risk of BD can be modulated by such…”
BackgroundEpigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis
Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L., Jia, P., Assadzadeh, A., Flanagan, J., Schumacher, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.008 · Cited by 773 · cited 3×
“, 2016), and one used CpG-island microarrays (Mill et al., 2008) for the assessment of methylation changes.”
BackgroundPruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699 · cited 2×
“…M anuscript A uthor M anuscript As a limitation, it is important to note that BDNF expression is highly dependent on the promoter being modulated (Pruunsild et al., 2007), as well as on genetic polymorphisms that can interfere with its processing and function (Egan et al., 2003; Hong et al.,…”
BackgroundWochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407498200 · Cited by 638
Self-citationDavies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R. A., Milosavljevic, A., Troakes, C., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-6-r43 · Cited by 630
Methyl-cpG-binding domain proteins: readers of the epigenome
Du, Q., Luu, P.-L., Stirzaker, C., & Clark, S. J. (2015) · Epigenomics · doi:10.2217/epi.15.39 · Cited by 544 · cited 1×
“At present, eleven proteins containing MBDs have been identified, of which the MeCP2 was the first described (Du et al., 2015).”
BackgroundHypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Abdolmaleky, H. M., Cheng, K.-H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl253 · Cited by 462 · cited 4×
“…have also been reported at the gene coding for the membrane-bound catechol-Omethyltransferase (MB-COMT), which is involved in the degradation of synaptic dopamine in the brain and is one of the most investigated genes in psychiatry (Abdolmaleky et al., 2006; Nohesara et al., 2011).”
BackgroundInfluentialDempster, E. L., Pidsley, R., Schalkwyk, L. C., Owens, S., Georgiades, A., Kane, F., Kalidindi, S., Picchioni, M., Kravariti, E., Toulopoulou, T., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr416 · Cited by 460 · cited 5×
“3.14 Genome-wide methylation studies Genome-wide methylation differences have also been analyzed in blood (Dempster et al., 2011; Houtepen et al., 2016; Li et al., 2015; Sabunciyan et al., 2015; Walker et al., 2016) and in different post-mortem brain regions, such as the BA9 (Zhao et al., 2015),…”
BackgroundMethodInfluentialDisease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446 · cited 2×
“…regulator of G protein signaling 4 (RGS4) gene in postmortem dorsolateral prefrontal cortex from patients with BD, schizophrenia, and healthy controls (Ding et al., 2016), following up on previous evidence of reduced expression of RGS4 in the brain of schizophrenic patients (Mirnics et al., 2001).”
BackgroundSmith, A. K., Kilaru, V., Klengel, T., Mercer, K. B., Bradley, B., Conneely, K. N., Ressler, K. J., & Binder, E. B. (2015) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32278 · Cited by 355
Epigenetic basis of mental illness
Nestler, E. J., Peña, C. J., Kundakovic, M., Mitchell, A., & Akbarian, S. (2016) · The Neuroscientist · doi:10.1177/1073858415608147 · Cited by 342
Walton, E., Hass, J., Liu, J., Roffman, J. L., Bernardoni, F., Roessner, V., Kirsch, M., Schackert, G., Calhoun, V., & Ehrlich, S. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv074 · Cited by 286 · cited 2×
“However, the studies on this topic are still controversial, and some findings indicate that most DNA methylation markers in peripheral blood do not reliably predict brain DNA methylation status (Walton et al., 2016).”
BackgroundValproate Induces widespread epigenetic reprogramming which involves demethylation of specific genes
Milutinovic, S., D'Alessio, A. C., Detich, N., & Szyf, M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl167 · Cited by 256
Frey, B. N., Andreazza, A. C., Houenou, J., Jamain, S., Goldstein, B. I., Frye, M. A., Leboyer, M., Berk, M., Malhi, G. S., Lopez-Jaramillo, C., et al. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413478217 · Cited by 234
D'Addario, C., Dell'Osso, B., Palazzo, M. C., Benatti, B., Lietti, L., Cattaneo, E., Galimberti, D., Fenoglio, C., Cortini, F., Scarpini, E., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.10 · Cited by 192
Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder
Abdolmaleky, H. M., Yaqubi, S., Papageorgis, P., Lambert, A. W., Ozturk, S., Sivaraman, V., & Thiagalingam, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.007 · Cited by 192
Weber-Stadlbauer, U., Richetto, J., Labouesse, M. A., Bohacek, J., Mansuy, I. M., & Meyer, U. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.41 · Cited by 170
Nohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M.-R., Ahmadkhaniha, H., Thiagalingam, S., & Abdolmaleky, H. M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.06.013 · Cited by 168
Epigenetic alterations in depression and antidepressant treatment
Menke, A., & Binder, E. B. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/amenke · Cited by 161
Genetic Determinants of Depression: Recent Findings and Future Directions
Dunn, E. C., Brown, R. C., Dai, Y., Rosand, J., Nugent, N. R., Amstadter, A. B., & Smoller, J. W. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000054 · Cited by 158 · cited 2×
“Introduction Complex psychiatric disorders, including mood disorders such as major depressive disorder (MDD) and bipolar disorder (BD), have been shown to run in families and present considerable heritability (Dunn et al., 2015; Kerner, 2015).”
BackgroundCarrard, A., Salzmann, A., Malafosse, A., & Karege, F. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.018 · Cited by 138 · cited 2×
“…including the serotonin transporter (5-HTT) and the serotonin receptor 1A (5-HTR1A), were shown to be increased in leukocytes and postmortem brain samples of BD patients, possibly explaining the decrease of their expression reported in patients (Abdolmaleky et al., 2014; Carrard et al., 2011).”
BackgroundEpigenetic aberration of the human REELIN gene in psychiatric disorders
Tamura, Y., Kunugi, H., Ohashi, J., & Hohjoh, H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001965 · Cited by 121 · cited 2×
“One study has examined methylation levels of the RELN gene in postmortem forebrains from patients as a means to further explore the regulation of RELN expression in BD (Tamura et al., 2007).”
BackgroundPerroud, N., Zewdie, S., Stenz, L., Adouan, W., Bavamian, S., Prada, P., Nicastro, R., Hasler, R., Nallet, A., Piguet, C., et al. (2016) · Depression and Anxiety · doi:10.1002/da.22406 · Cited by 120
Dell׳Osso, B., D׳Addario, C., Carlotta Palazzo, M., Benatti, B., Camuri, G., Galimberti, D., Fenoglio, C., Scarpini, E., Di Francesco, A., Maccarrone, M., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.020 · Cited by 112 · cited 5×
“, 2010), as well as of the BDNF gene in peripheral blood mononuclear cells (PBMCs) from patients (D’Addario et al., 2012; Dell’Osso et al., 2014) and in rat hippocampal neurons (Dwivedi and Zhang, 2014).”
BackgroundResultInfluentialChen, C., Zhang, C., Cheng, L., Reilly, J. L., Bishop, J. R., Sweeney, J. A., Chen, H., Gershon, E. S., & Liu, C. (2014) · Bipolar Disorders · doi:10.1111/bdi.12255 · Cited by 105
Abdolmaleky, H. M., Nohesara, S., Ghadirivasfi, M., Lambert, A. W., Ahmadkhaniha, H., Ozturk, S., Wong, C. K., Shafa, R., Mostafavi, A., & Thiagalingam, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.12.007 · Cited by 102 · cited 2×
“…including the serotonin transporter (5-HTT) and the serotonin receptor 1A (5-HTR1A), were shown to be increased in leukocytes and postmortem brain samples of BD patients, possibly explaining the decrease of their expression reported in patients (Abdolmaleky et al., 2014; Carrard et al., 2011).”
BackgroundRuzicka, W. B., Subburaju, S., & Benes, F. M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.49 · Cited by 101 · cited 1×
“Abnormal expression of this gene has been reported in schizophrenia and BD, and there are diagnosis- and circuit-specific DNA methylation changes at a subset of GAD1 regulatory network genes in the hippocampus in these disorders (Ruzicka et al., 2015).”
BackgroundEffect of mood stabilizers on DNA methylation in human neuroblastoma cells
Asai, T., Bundo, M., Sugawara, H., Sunaga, F., Ueda, J., Tanaka, G., Ishigooka, J., Kasai, K., Kato, T., & Iwamoto, K. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000710 · Cited by 68 · cited 3×
“Regarding other mood stabilizers, carbamazapine has been shown to induce hypermethylation of 64 genes and hypomethylation of 14 genes in a neuroblastoma cell line (Asai et al., 2013), while lamotrigine induced no changes in global DNA methylation in another study (Perisic et al., 2010).”
BackgroundBias in emerging biomarkers for bipolar disorder
Carvalho, A. F., Köhler, C. A., Fernandes, B. S., Quevedo, J., Miskowiak, K. W., Brunoni, A. R., Machado-Vieira, R., Maes, M., Vieta, E., & Berk, M. (2016) · Psychological Medicine · doi:10.1017/s0033291716000957 · Cited by 63 · cited 1×
“Of note, no biomarker has yet been approved for its diagnosis or prognosis (Carvalho et al., 2016; Frey et al., 2013).”
BackgroundSelf-citationFKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications
Gassen, N. C., Hartmann, J., Zannas, A. S., Kretzschmar, A., Zschocke, J., Maccarrone, G., Hafner, K., Zellner, A., Kollmannsberger, L. K., Wagner, K. V., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.38 · Cited by 62
Self-citationSales, A. J., & Joca, S. R. L. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.40 · Cited by 62 · cited 1×
“In fact, preclinical studies in animal models of relevance for BD show promising results (Sales et al., 2011; Sales and Joca, 2016), and studies have shown that targeting DNMT is a crucial part of the mechanism of action of antidepressants and the resolution of depressive symptoms (Gassen et al.,…”
BackgroundAssociation of DNA Methylation with Acute Mania and Inflammatory Markers
Sabunciyan, S., Maher, B., Bahn, S., Dickerson, F., & Yolken, R. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132001 · Cited by 35
Cited by
Revisiting inflammation in bipolar disorder
Fries, G. R., Walss-Bass, C., Bauer, M. E., & Teixeira, A. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.006 · Cited by 147
Self-citationToward Precision Psychiatry in Bipolar Disorder: Staging 2.0
Salagre, E., Dodd, S., Aedo, A., Rosa, A., Amoretti, S., Pinzon, J., Reinares, M., Berk, M., Kapczinski, F. P., Vieta, E., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00641 · Cited by 106
“Besides genetic markers, screening for risk factors and epigenetic modifications may be another useful tool at at-risk stages of the disease, given that stressful life events, particularly childhood trauma, can alter DNA methylation and may increase the risk of developingmood disorders (75).”
BackgroundEpigenetics in bipolar disorder: a critical review of the literature
Legrand, A., Iftimovici, A., Khayachi, A., & Chaumette, B. (2021) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000267 · Cited by 48
Metadata
- Authors
- Fries, G. R., Li, Q., McAlpin, B., Rein, T., Walss-Bass, C., Soares, J. C., & Quevedo, J.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 68
- Pages
- 474-488
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2440103894
- Cited by
- 81
- References
- 43
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.